| Literature DB >> 31699069 |
Naoki Deguchi1,2, Yoshiyuki Hirakawa3, Shota Izawa4, Kazuhito Yokoyama4, Keito Muraki4, Ryouiti Oshibuti4, Yasuki Higaki5,6.
Abstract
BACKGROUND: Pain neuroscience education (PNE) has been shown to reduce pain or psychological symptoms in patients with chronic pain and preoperative knee osteoarthritis; however, the evidence of its effectiveness in hospitalized patients who have undergone high tibial osteotomy (HTO) is unknown. This study was performed to determine whether the implementation of a newly developed hospital-time PNE provided by physical therapists to patients after HTO can result in meaningful improvements.Entities:
Keywords: Catastrophizing; Education; Knee osteoarthritis; Physical therapist; Propensity score matching
Mesh:
Year: 2019 PMID: 31699069 PMCID: PMC6839222 DOI: 10.1186/s12891-019-2913-5
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Pain neuroscience education content
| Session/time | Lecture | Practice |
|---|---|---|
| 1. Purpose of the education | • Fear avoidance model | • Goal setting |
| 1 week postoperatively | • Rehabilitation and education schedule | |
| 2. Pain in knee osteoarthritis | • Biological psychology model | • Cognitive restructuring |
| 2–5 weeks postoperativelya | • Descending inhibitory pathways | |
| 3. Pain and sleep | • Sleep hygiene education | • Mindfulness |
| 2–5 weeks postoperativelya | • Descending pain modulatory systems | • Distraction |
| 4. Pain and lifestyle | • Pain and inactivity | • Activity pacing |
| 2–5 weeks postoperativelya | • Effects of nutrition on inflammation | |
| 5. Self-management | • Social cognitive theory | • Decisional balance |
| 2–5 weeks postoperativelya | • Willpower and brain |
aAttend at random
Fig. 1Study Protocol
Baseline descriptive characteristics before and after propensity score matching
| Control | Intervention | |||||||
|---|---|---|---|---|---|---|---|---|
| Unadjusted | Adjusted | |||||||
| ( | ( | ( | ||||||
| Mean (SD) age, years | 63.7 | (8.6) | 67.0 | (8.3) | 0.042 | 66.2 | (8.0) | 0.146 |
| Female, n (%) | 32 | (67) | 46 | (75) | 0.393 | 37 | (77) | 0.364 |
| Mean (SD) height, cm | 158.4 | (9.2) | 157.4 | (7.4) | 0.549 | 157.4 | (6.5) | 0.552 |
| Mean (SD) weight, kg | 65.9 | (13.1) | 61.7 | (10.7) | 0.069 | 62.0 | (11.0) | 0.117 |
| Mean (SD) BMI, kg/m2 | 26.1 | (3.9) | 24.8 | (3.4) | 0.072 | 24.9 | (3.6) | 0.127 |
| Symptom duration, n (%) | ||||||||
| < 3 mo | 36 | (69) | 43 | (64.2) | 0.415 | 33 | (63.5) | 0.678 |
| 3–6 mo | 4 | (8) | 3 | (4.5) | 3 | (5.8) | ||
| 6–1 y | 4 | (8) | 3 | (4.5) | 3 | (5.8) | ||
| > 1 y | 8 | (15) | 18 | (26.9) | 13 | (25.0) | ||
| Complications, n (%) | ||||||||
| Diabetes | 15 | (29) | 17 | (25) | 0.683 | 9 | (17) | 0.244 |
| Hypertension | 28 | (54) | 29 | (43) | 0.272 | 24 | (46) | 0.557 |
| Varicose veins | 10 | (19) | 25 | (37) | 0.042 | 17 | (33) | 0.179 |
| Radiation severity, n (%) | ||||||||
| Operative side | ||||||||
| Kellgren–Lawrence grade | 0.113 | 0.148 | ||||||
| II | 11 | (21) | 26 | (39) | 20 | (38.5) | ||
| III | 27 | (52) | 25 | (37) | 20 | (38.5) | ||
| IV IV | 14 | (27) | 16 | (24) | 12 | (23) | ||
| Nonoperative side Nonoperative side | 0.662 | 0.563 | ||||||
| Kellgren–Lawrence grade Kellgren–Lawrence grade | ||||||||
| Non-KOA | 31 | (59.6) | 33 | (49.3) | 26 (50) | |||
| II | 2 | (3.8) | 2 | (3.0) | 1 (2) | |||
| III | 2 | (3.8) | 7 | (10.4) | 4 (8) | |||
| IV | 1 | (1.9) | 2 | (3.0) | 0 (0) | |||
| Postoperatively | 16 | (30.8) | 23 | (34.3) | 21 (40) | |||
| Hospitalization month, n (%) | ||||||||
| 3–5 | 16 | (31) | 12 | (18) | 0.311 | 11 | (21) | 0.587 |
| 6–8 | 12 | (23) | 24 | (36) | 17 | (33) | ||
| 9–11 | 16 | (31) | 21 | (31) | 17 | (33) | ||
| 12–2 | 8 | (15) | 10 | (15) | 7 | (13) | ||
SD standard deviation, BMI body mass index, KOA knee osteoarthritis
Comparison of baseline and follow-up outcomes in each group
| Outcomes | (n) | Intervention | (n) | Control | ||||
|---|---|---|---|---|---|---|---|---|
| Baseline | Follow-up | Baseline | Follow-up | |||||
| Primary (NRS score; 0–10) | ||||||||
| Pain at rest | 2.0 (2.6) | 1.1 (1.3) | 0.033 | 1.9 (2.3) | 0.8 (1.2) | 0.001 | ||
| Pain during walking | 4.7 (2.3) | 2.2 (1.4) | < 0.001 | 4.2 (2.8) | 2.6 (2.1) | 0.003 | ||
| Secondary | ||||||||
| PCS score (0–52) | 30.3 (6.5) | 16.9 (9.7) | < 0.001 | 30.8 (7.7) | 20.7 (8.4) | < 0.001 | ||
| PSEQ score (0–60) | 37.6 (10.6) | 43.4 (10.2) | 0.005 | 36.3 (11.1) | 38.7 (12.8) | 0.215 | ||
| Knee extension (kgf/kg) | ||||||||
| Operative side | 0.25 (0.09) | 0.22 (0.10) | 0.071 | 0.30 (0.14) | 0.30 (0.13) | 0.827 | ||
| Nonoperative side | 0.31 (0.09) | 0.35 (0.11) | 0.015 | 0.30 (0.14) | 0.33 (0.14) | 0.126 | ||
| 10-m walking test (s) | 8.9 (3.2) | 9.6 (2.4) | 0.186 | 9.1 (3.3) | 10.5 (7.6) | 0.135 | ||
Data are presented as mean (standard deviation). Baseline: preoperative, Follow-up: 5 weeks postoperatively, NRS numerical rating scale, PCS Pain Catastrophizing Scale, PSEQ Pain Self-Efficacy Questionnaire
Comparison of baseline and follow-up outcomes between groupsa
| Follow-up to baseline | Difference in change between groupsa | ||||
|---|---|---|---|---|---|
| Intervention | Control | Mean (95% CI) | Cohen’s d | ||
| Primary | |||||
| Pain at rest (NRS) | −1.0 (0.9) | − 1.1 (1.0) | 0.1 (−0.2, 0.4) | 0.470 | 0.07 |
| Pain during walking (NRS) | −2.1 (1.6) | −1.9 (1.7) | −0.2 (− 0.8, 0.4) | 0.460 | 0.14 |
| Secondary | |||||
| Pain catastrophizing (PCS) | −13.7 (8.6) | −9.9 (8.7) | −3.8 (−0.2, −7.4) | 0.036 | 0.44 |
| Self-efficacy (PSEQ) | 6.0 (10.3) | 2.1 (10.5) | 4.0 (−0.3, 8.3) | 0.070 | 0.38 |
| Knee extension | |||||
| Operative side | −0.03 (0.14) | 0.00 (0.13) | −0.03 (− 0.08, 0.03) | 0.350 | 0.19 |
| Nonoperative side | 0.05 (0.11) | 0.02 (0.12) | 0.03 (−0.02, 0.07) | 0.248 | 0.24 |
| 10-m walking test | 0.1 (5.5) | 1.8 (5.0) | −1.7 (−3.8, 0.5) | 0.121 | 0.32 |
Data in first two columns are presented as mean (standard deviation). Baseline: preoperative, Follow-up: 5 weeks postoperatively, 95% CI 95% confidence interval, NRS numerical rating scale, PCS Pain Catastrophizing Scale, PSEQ Pain Self-Efficacy Questionnaire. aValues adjusted for baseline scores using analysis of covariance
MCID of primary outcome
| n (%) | RR (95% CI) | |||
|---|---|---|---|---|
| Intervention | Control | |||
| MCID for pain at rest (NRS) | ||||
| 2.0 units of improvement | ||||
| Yes | 16 (36) | 18 (35) | 0.18 | 1.03 (0.76, 1.34) |
| No | 28 (64) | 34 (65) | ||
| MCID for pain during walking (NRS) | ||||
| 2.0 units of improvement | ||||
| Yes | 25 (60) | 24 (51) | 0.35 | 1.21 (0.76, 1.93) |
| No | 17 (40) | 23 (49) | ||
MCID minimal clinically important difference, RR relative risk, 95% CI: 95% confidence interval, NRS numerical rating scale
Comparison of baseline and follow-up outcomes between the two groups by intention-to-treat analysisa
| Follow-up to baseline | Difference in change between groups | ||||
|---|---|---|---|---|---|
| Intervention | Control | Mean (95% CI) | Cohen’s d | ||
| Primary | |||||
| Rest (NRS)b | −0.9 (1.0) | −1.0 (1.0) | 0.1 (−0.2, 0.4) | 0.65 0.11 | |
| Pain during walking (NRS)c | −2.0 (1.7) | −1.8 (1.7) | −0.2 (− 0.9, 0.4) | 0.47 0.14 | |
| Secondary | |||||
| Pain catastrophizing (PCS)d | −13.4 (8.7) | −10.0 (8.6) | −3.5 (−6.9, 0.0) | 0.050 0.40 | |
| Self-efficacy (PSEQ)e | 4.8 (10.7) | 2.0 (10.9) | 2.8 (−1.5, 7.1) | 0.20 0.26 | |
| Quadriceps muscle strength | |||||
| Operative sidef | −0.03 (0.14) | 0.00 (0.12) | −0.03 (− 0.08, 0.03) | 0.35 0.23 | |
| Nonoperative sideg | 0.05 (0.11) | 0.02 (0.11) | 0.03 (−0.02, 0.07) | 0.25 0.27 | |
| 10-m walking testh | 0.3 (5.1) | 1.8 (4.8) | −1.5 (−3.5, 0.5) | 0.147 0.3 | |
Data in first two columns are presented as mean (standard deviation). Baseline: preoperative, Follow-up: 5 weeks postoperatively, PNE pain neuroscience education, Reha: rehabilitation, 95% CI: 95% confidence level, NRS numerical rating scale, PCS Pain Catastrophizing Scale, PSEQ Pain Self-Efficacy Questionnaire
aValues adjusted for baseline scores using analysis of covariance
bIntervention (n = 50), Control (n = 52)
cIntervention (n = 48), Control (n = 47)
dIntervention (n = 49), Control (n = 48), eIntervention (n = 48), Control (n = 48)
fIntervention (n = 43), Control (n = 48)
gIntervention (n = 43), Control (n = 44)
hIntervention (n = 41), Control (n = 47)